1. Aims: Demyelination plays a crucial role in neurodegenerative processes and traumatic disorders. One possibility to achieve remyelination and subsequent restoration of neuronal function is to provide an exogenous source of myelinating cells via transplantation. In this context, mesenchymal stem cells (MSCs) have attracted interest. They are multipotent stem cells that differentiate into cells of the mesodermal lineage like bone, cartilage, fat, and muscle. Although adult, their differentiation potential is remarkable, and they are able to transdifferentiate.
2. Methods: We transformed cultivated rat MSCs into myelinating cells by using a cytokine cocktail. Transdifferentiated MSCs were characterized by an enhanced expression of LNGF-receptor, Krox20, and CD104, and a decreased expression of BMP receptor-1A as compared to untreated MSCs. The myelinating capacity was evaluated in vitro and in vivo. Therefore, PC12 cells, normally unmyelinated, were cocultivated with MSCs, transdifferentiated MSCs, and Schwann cells, or the respective cells were grafted into an autologous muscle conduit bridging a 2-cm gap in the rat sciatic nerve. Myelination of PC12 cells was demonstrated by electron microscopy. In vivo, after 3 and 6 weeks regeneration including myelination was monitored histologically and morphometrically. Autologous nerves and cell-free muscle grafts were used as control.
3. Results: Schwann cells and transdifferentiated MSCs were able to myelinate PC12 cells after 14 days in vitro. In vivo, autologous nerve grafts demonstrated the best results in all regenerative parameters. An appropriate myelination was noted in the Schwann cell groups and, albeit with restrictions, in the transdifferentiated MSC groups, while regeneration in the MSC groups and in the cell-free groups was impaired.
4. Conclusion: Our findings demonstrate that it may be possible to differentiate MSCs into therapeutically useful cells for clinical applications in myelin defects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Akiyama, Y., Radtke, C., and Kocsis, J. D. (2002). Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci. 22:6623–6630.
Bachelin, C., Lachapelle, F., Girard, C., Moissonnier, P., Serguera-Lagache, C., Mallet, J., Fontaine, D., Chonjnowski, A., Le Guern, E., Nait-Oumesmar, B., and Baron-Van Evercooren, A. (2005). Efficient myelin repair in the macaque spinal cord autologous grafts of Schwann cells. Brain 128:540–549.
Blakemore, W. F. (1977). Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature 266:68–69.
Calderon-Martinez, D., Garavito, Z., Spinel, C., and Hurtado, H. (2002). Schwann cell-enriched cultures from adult human peripheral nerve: A technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C). J. Neurosci. Methods 114:1–8.
Chan, J. R., Watkins, T. A., Cosgaya, J. M., Zhang, C., Chen, L., Reichardt, L. F., Shooter, E. M., and Barres, B. A. (2004). NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43:183–191.
Cheng, H. L., Shy, M., and Feldman, E. L. (1999). Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. Endocrinology 140:4478–4485.
Cohen, R. I., McKay, R., and Almazan, G. (1999). Cyclic AMP regulates PDGF-stimulated signal transduction and differentiation of an immortalized optic-nerve-derived cell line. J. Exp. Biol. 202:461–473.
Cuevas, P., Carceller, F., Dujovny, M., Garcia-Gomez, I., Cuevas, B., Gonzalez-Corrochano, R., Diaz-Gonzalez, D., and Reimers, D. (2002). Peripheral nerve regeneration by bone marrow stromal cells. Neurol. Res. 24:634–638.
Deber, C. M., and Reynolds, S. J. (1991). Central nervous system myelin: Structure, function, and pathology. Clin. Biochem. 24:113–134.
Deng, W., Obrocka, M., Fischer, I., and Prockop, D. J. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun. 282:148–152.
Dezawa, M. (2002). Central and peripheral nerve regeneration by transplantation of Schwann cells and transdifferentiated bone marrow stromal cells. Anat. Science Int. 77:12–25.
Dezawa, M., Takahashi, I., Esaki, M., Takano, M., and Sawada, H. (2001). Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur. J. Neurosci. 14:1771–1776.
Donato, R. (2001). S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 33:637–668.
Fansa, H., and Keilhoff, G. (2004). Comparison of different biogenic matrices seeded with cultured Schwann cells for bridging peripheral nerve defects. Neurol. Res. 26:167–173.
Fansa, H., Keilhoff, G., Plogmeier, K., Frerichs, O., Wolf, G., and Schneider, W. (1999). Successful implantation of Schwann cells in acellular muscle. J. Reconstr. Microsurg. 15:61–65.
Fansa, H., Keilhoff, G., Wolf, G., and Schneider, W. (2001). Tissue engineering of peripheral nerves: A comparison of venous and acellular muscle grafts with cultured Schwann cells. Plast. Reconstr. Surg. 107:485–494.
Fortino, V., Torricelli, C., Gardi, C., Valacchi, G., Rossi Paccani, S., and Maioli, E. (2002). ERKs are the point of divergence of PKA and PKC activation by PTHrP in human skin fibroblasts. Cell. Mol. Life Sci. 59:2165–2171.
Fraichard, A., Chassande, O., Bilbaut, G., Dehay, C., Savatier, P., and Samarut, J. (1995). In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J. Cell Sci. 108:3181–3188.
Hoffmann, A., and Gross, G. (2001). BMP signaling pathways in cartilage and bone formation. Crit. Rev. Eukaryot. Gene Expr. 11:23–45.
Honmou, O., Felts, P. A., Waxman, S. G., and Koscis, J. D. (1996). Restoration of normal conduction properties in dfemyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J. Neurosci. 16:3199–3208.
Ide, C. (1996). Peripheral nerve regeneration. Neurosci. Res. 25:101–121.
Itoh, K., Fushiki, S., Kamiguchi, H., Arnold, B., Altevogt, P., and Lemmon, V. (in press). Disrupted Schwann cell–axon interactions in peripheral nerves of mice with altered L1-integrin interactions. Mol. Cell. Neurosci.
Jessen, K. R., and Mirsky, R. (2002). Signals that determine Schwann cell identity. J. Anat. 200:367–376.
Kamada, T., Koda, M., Dezawa, M., Yoshinaga, K., Hishimoto, M., Koshizuka, S., Nishio, Y., Moriya, H., and Yamazaki, M. (2005). Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J. Neuropathol. Exp. Neurol. 64:37–45.
Kashofer, K., and Bonnet, D. (in press). Gene therapy progress and prospects: Stem cell plasticity. Gene Ther.
Keilhoff, G., Fansa, H., Schneider, W., and Wolf, G. (1999). In vivo predegeneration of peripheral nerves: An effective technique to obtain activated Schwann cells for nerve conduits. J. Neurosci. Methods 89:8917–8924.
Keilhoff, G., Fansa, H., Smalla, K. H., Schneider, W., and Wolf, G. (2000). Neuroma: A donor-age independent source of human Schwann cells for tissue engineered nerve grafts. Neuroreport 11:3805–3809.
Keilhoff, G., Stang, F., Goihl, A., Wolf, G., and Fansa, H. (in press). Peripheral nerve tissue engineering—autologous Schwann cells vs. transdifferentiated mesenchymal stem cells. Tissue Eng.
Kocsis, J. D., Akiyama, Y., Lankford, K. L., and Radtke, C. (2002). Cell transplantation of peripheral-myelin-forming cells to repair the injured spinal cord. J. Rehabil. Res. Dev. 39:287–298.
Kopen, G. C., Prockop, D. J., and Phinney, D. G. (2001). Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U.S.A. 96:10711–10716.
Liu, H. M., Yang, L. H., and Yang, Y. J. (1995). Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J. Neuropathol. Exp. Neurol. 54:487–496.
Magnaghi, V., Cavarretta, I., Galbiati, M., Martini, L., and Melcangi, R. C. (2001). Neuroactive steroids and peripheral myelin proteins. Brain Res. Brain Res. Rev. 37:360–371.
Mimura, T., Dezawa, M., Kanno, H., Sawada, H., and Yamamoto, I. (2004). Peripheral nerve regeneration by transplantation of bone marrow stromal cell-derived Schwann cells in adult rats. J. Neurosurg. 101:806–812.
Mirsky, R., and Jessen, K. R. (1999). The neurobiology of Schwann cells. Brain Pathol. 9:293–311.
Morrissey, T. K., Kleitman, N., and Bunge, R. P. (1991). Isolation and functional characterization of Schwann cells derived from adult peripheral nerve. J. Neurosci. 11:2433–2442.
Near, S. L., Whalen, L. R., Miller, J. A., and Ishii, D. N. (1992). Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. U.S.A. 89:11716–11720.
Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser, M., and Werner, C. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377–384.
Otsuka, E., Yamaguchi, A., Hirose, S., and Hagiwara, H. (1999). Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am. J. Physiol. 277:132–138.
Parkinson, D. B., Bhaskaran, A., Droggiti, A., Dickinson, S., D’Antonio, M., Mirsky, R., and Jessen, K. R. (2004). Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J. Cell Biol. 164:385–395.
Phinney, D. G., Kopen, G., Isaacson, R. L., and Prockop, D. J. (1999). Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation. J. Cell. Biochem. 72:570–585.
Pittenger, M. F., and Martin, B. J. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95:9–20.
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147.
Previtali, S. C., Nodari, A., Taveggia, C., Pardini, C., Dina, G., Villa, A., Wrabetz, L., Quattrini, A., and Feltri, M. L. (2003). Expression of laminin receptors in Schwann cell differentiation: Evidence for distinct roles. J. Neurosci. 23:5520–5530.
Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74.
Rong, L. L., Trojaborg, W., Qu, W., Kostov, K., Yan, S. D., Gooch, C., Szabolcs, M., Hays, A. P., and Schmidt, A. M. (2004). Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J. 18:1812–18127.
Rutenberg, M. S., Hamazaki, T., Singh, A. M., and Terada, N. (2004). Stem cell plasticity, beyond alchemy. Int. J. Hematol. 79:15–21.
Schröder, J. M. (2001). Pathology of Peripheral Nerves. Springer-Verlag, Berlin Heidelberg, New York.
Stoll, G., and Müller, H. W. (1999). Nerve injury, axonal degeneration and neural regeneration: Basic insights. Brain Pathol. 9:313–325.
Tohill, M., and Terenghi, G. (2004). Stem-cell plasticity and therapy for injuries of the peripheral nervous system. Bitechnol. Appl. Biochem. 40:17–24.
Tohill, M., Mantovani, C., Wiberg, M., and Terenghi, G. (2004). Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci. Lett. 362:200–203.
Wiberg, M., and Terenghi, G. (2003). Will it be possible to produce peripheral nerves? Surg. Technol. Int. 11:303–310.
Woodbury, D., Schwarz, E. J., Prockop, D. J., and Black, I. B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364–370.
ACKNOWLEDGMENTS
We would like to thank Karla Klingenberg and Leona Bück for their contributions to our experiments. This work was supported by grants from the Hertie-Stiftung (Kei 1.01.1/03/011) and the Zinkann-Stiftung.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keilhoff, G., Stang, F., Goihl, A. et al. Transdifferentiated Mesenchymal Stem Cells as Alternative Therapy in Supporting Nerve Regeneration and Myelination. Cell Mol Neurobiol 26, 1233–1250 (2006). https://doi.org/10.1007/s10571-006-9029-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-006-9029-9